United States Pneumococcal Vaccine Market - Industry Analysis, Size, Share, Growth, Trends, and Forecasts 2025
22nd September 2018 - United
States Pneumococcal Vaccines Market is expected to grow at a
significant CAGR in the upcoming years as the scope, product types, and its
applications are increasing across the globe. Pneumococcal Vaccines, as the
name suggests, guard against the bacteria termed as “Streptococcus pneumoniae”.
Their use could check certain cases of meningitis, pneumonia, and sepsis. The
polysaccharide vaccines and conjugate vaccines are two types of pneumococcal
vaccines. In addition, under the skin or into the muscle this pneumococcal
injection is given.
Furthermore,
through the vaccination, the prevention of the disease is one of the safest
ways and cost-effective. Pneumococcus is one of the leading causes of
pneumonia, blood infection, meningitis, otitis media, and sinusitis. It is one
of the leading infectious diseases. With a rise in pneumococcal disease due to
causative serotype, the need for vaccines with larger coverage has enlarged.
View Full Report
with TOC @ https://www.millioninsights.com/industry-reports/united-states-pneumococcal-vaccines-market
Additionally,
the companies are also working on introducing new and inexpensive Pneumococcal
Vaccines particularly for emerging countries. There has also been a rise in
investment in the research and development activities to produce vaccines at
lower cost. United States Pneumococcal Vaccines Industry is categorized based
on product type, applications, and geography. United States Pneumococcal
Vaccines Market is categorized based on product types such as Pneumococcal
Conjugate Vaccine (PCV13), Pneumococcal Polysaccharide Vaccine (PPSV23).
United
States Pneumococcal Vaccines Market is categorized based on application into
Pneumonia, Meningitis, and Sepsis. United States Pneumococcal Vaccines Industry
is categorized based on geography into The West, The Southwest, The Middle
Atlantic, New England, The South and The Midwest. Some of the key players that
fuel the growth of the United States Pneumococcal Vaccines Market include
Celgene Corporation, Pfizer, Merck, Genocea Biosciences, Eli Lilly,
AstraZeneca, Nuron Biotech, Beijing Minhai Biotechnology, Sanofi Pasteur,
Abera, S K Chemicals, Baxter, Biken, Sanofi, GlaxoSmithKline, Sinovac, Panacea
Biotec, Genentech, Immunobiology, Valneva Austria, Biogen. The key players are
focusing on inorganic growth to sustain themselves amidst fierce competition.
As such, mergers, acquisitions, and joint ventures are the need of the hour.
Market Segment:
Geographically, this report splits the
United States market into seven regions:
•
The West
•
Southwest
•
The Middle Atlantic
•
New England
•
The South
•
The Midwest
with
sales (volume), revenue (value), market share and growth rate of Pneumococcal
Vaccine in these regions, from 2013 to 2025 (forecast).
United States Pneumococcal Vaccine
market competition by top manufacturers/players, with Pneumococcal Vaccine
sales volume, price, revenue (Million USD) and market share for each
manufacturer/player; the top players including
•
MSD
•
Sanofipasteur
•
CDIB
•
Pfizer
•
GSK
Request Sample
Copy of This Report @ https://www.millioninsights.com/industry-reports/united-states-pneumococcal-vaccines-market/request-sample
Comments
Post a Comment